Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-08-19
DOI
10.1038/srep13157
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression and Significance of CD44, CD47 and c-met in Ovarian Clear Cell Carcinoma
- (2015) Huimin Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CD44 as a potential diagnostic tumor marker
- (2015) Nawwaf Basakran SAUDI MEDICAL JOURNAL
- Expression of stem cell marker CD44 in prostate cancer biopsies predicts cancer grade in radical prostatectomy specimens
- (2015) Konstanty Korski et al. POLISH JOURNAL OF PATHOLOGY
- Isolation and characterization of multipotent mesenchymal stem cells in nasal polyps
- (2014) Jung-Sun Cho et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas
- (2014) Shuji Mikami et al. INTERNATIONAL JOURNAL OF CANCER
- Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma
- (2013) Kefeng Wang et al. MEDICAL ONCOLOGY
- CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
- (2013) Shicai Chen et al. PLoS One
- Molecular characterization of kidney cancer
- (2011) Andrew Chi et al. CANCER
- CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression
- (2011) Rhonda L. Brown et al. JOURNAL OF CLINICAL INVESTIGATION
- EGFR mutation: Significance as a stratification factor in the era of molecular-targeted therapy
- (2011) YOUNG HAK KIM et al. Oncology Letters
- Understanding the cancer stem cell
- (2010) S Bomken et al. BRITISH JOURNAL OF CANCER
- CD44, a therapeutic target for metastasising tumours
- (2010) Véronique Orian-Rousseau EUROPEAN JOURNAL OF CANCER
- Frequency and pattern of expression of the stem cell marker CD133 have strong prognostic effect on the surgical outcome of colorectal cancer patients
- (2010) Takahashi ONCOLOGY REPORTS
- Metastatic renal cell cancer treatments: An indirect comparison meta-analysis
- (2009) Edward J Mills et al. BMC CANCER
- Prognostic Significance of the Cancer Stem Cell Markers CD133, CD44, and CD166 in Colorectal Cancer
- (2009) David Horst et al. CANCER INVESTIGATION
- Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
- (2008) Kiran Gupta et al. CANCER TREATMENT REVIEWS
- Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression
- (2008) Lilly Y.W. Bourguignon SEMINARS IN CANCER BIOLOGY
- Isolation and Characterization of Multipotent Human Keloid-Derived Mesenchymal-Like Stem Cells
- (2008) Jai-Hee Moon et al. STEM CELLS AND DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation